CD8A and type 2 diabetes mellitus: Next, we investigated whether cell-mediated immune (CMI) responses to SARS-CoV-2 differed between Lepr-deficient, T2DM and lean mice, by analyzing murine splenic T-lymphocyte (CD4+ and CD8+)-specific responses.